Cargando…

A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study

High postprandial blood glucose levels are associated with increased mortality, cardiovascular events and development of diabetes in the general population. Interventions targeting postprandial glucose have been shown to prevent both cardiovascular events and diabetes. This study evaluates the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Östman, Elin, Samigullin, Azat, Heyman-Lindén, Lovisa, Andersson, Kristina, Björck, Inger, Öste, Rickard, Humpert, Per M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313729/
https://www.ncbi.nlm.nih.gov/pubmed/32579549
http://dx.doi.org/10.1371/journal.pone.0234237
_version_ 1783549995721424896
author Östman, Elin
Samigullin, Azat
Heyman-Lindén, Lovisa
Andersson, Kristina
Björck, Inger
Öste, Rickard
Humpert, Per M.
author_facet Östman, Elin
Samigullin, Azat
Heyman-Lindén, Lovisa
Andersson, Kristina
Björck, Inger
Öste, Rickard
Humpert, Per M.
author_sort Östman, Elin
collection PubMed
description High postprandial blood glucose levels are associated with increased mortality, cardiovascular events and development of diabetes in the general population. Interventions targeting postprandial glucose have been shown to prevent both cardiovascular events and diabetes. This study evaluates the efficacy and safety of a novel nutritional supplement targeting postprandial glucose excursions in non-diabetic adults. Sixty overweight healthy male and female participants were recruited at two centers and randomized in a double-blind, placebo-controlled, crossover design. The supplement, a water-based drink containing 2.6g of amino acids (L-Leucine, L-Threonine, L-Lysine Monohydrochloride, L-Isoleucine, L-Valine) and 250 mcg of chromium picolinate, was consumed with a standardized carbohydrate-rich meal. The primary endpoint was the incremental area under the curve (iAUC) for venous blood glucose from 0 to 120 minutes. Secondary endpoints included glucose iAUC (0–180 minutes) and the maximum glucose concentration (C(max)), for both venous and capillary blood glucose. In the intention-to-treat-analysis (n = 60) the supplement resulted in a decreased venous blood glucose iAUC(0-120min) compared to placebo, mean (SE) of 68.7 (6.6) versus 52.2 (6.8) respectively, a difference of -16.5 mmol/L•min (95% CI -3.1 to -30.0, p = 0.017). The C(max) for venous blood glucose for the supplement and placebo were 6.45 (0.12) versus 6.10 (<0.12), respectively, a difference of -0.35 mmol/L (95% CI -0.17 to -0.53, p<0.001). In the per protocol-analysis (n = 48), the supplement resulted in a decreased C(max) compared to placebo from 6.42 (0.14) to 6.12 (0.14), a difference of -0.29 mmol/L (95% CI -0.12 to -0.47, p = 0.002). No significant differences in capillary blood glucose were found, as measured by regular bed-side glucometers. The nutritional supplement drink containing amino acids and chromium improves the postprandial glucose homeostasis in overweight adults without diabetes. Future studies should clarify, whether regular consumption of the supplement improves markers of disease or could play a role in a diet aiming at preventing the development of diabetes.
format Online
Article
Text
id pubmed-7313729
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-73137292020-06-26 A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study Östman, Elin Samigullin, Azat Heyman-Lindén, Lovisa Andersson, Kristina Björck, Inger Öste, Rickard Humpert, Per M. PLoS One Research Article High postprandial blood glucose levels are associated with increased mortality, cardiovascular events and development of diabetes in the general population. Interventions targeting postprandial glucose have been shown to prevent both cardiovascular events and diabetes. This study evaluates the efficacy and safety of a novel nutritional supplement targeting postprandial glucose excursions in non-diabetic adults. Sixty overweight healthy male and female participants were recruited at two centers and randomized in a double-blind, placebo-controlled, crossover design. The supplement, a water-based drink containing 2.6g of amino acids (L-Leucine, L-Threonine, L-Lysine Monohydrochloride, L-Isoleucine, L-Valine) and 250 mcg of chromium picolinate, was consumed with a standardized carbohydrate-rich meal. The primary endpoint was the incremental area under the curve (iAUC) for venous blood glucose from 0 to 120 minutes. Secondary endpoints included glucose iAUC (0–180 minutes) and the maximum glucose concentration (C(max)), for both venous and capillary blood glucose. In the intention-to-treat-analysis (n = 60) the supplement resulted in a decreased venous blood glucose iAUC(0-120min) compared to placebo, mean (SE) of 68.7 (6.6) versus 52.2 (6.8) respectively, a difference of -16.5 mmol/L•min (95% CI -3.1 to -30.0, p = 0.017). The C(max) for venous blood glucose for the supplement and placebo were 6.45 (0.12) versus 6.10 (<0.12), respectively, a difference of -0.35 mmol/L (95% CI -0.17 to -0.53, p<0.001). In the per protocol-analysis (n = 48), the supplement resulted in a decreased C(max) compared to placebo from 6.42 (0.14) to 6.12 (0.14), a difference of -0.29 mmol/L (95% CI -0.12 to -0.47, p = 0.002). No significant differences in capillary blood glucose were found, as measured by regular bed-side glucometers. The nutritional supplement drink containing amino acids and chromium improves the postprandial glucose homeostasis in overweight adults without diabetes. Future studies should clarify, whether regular consumption of the supplement improves markers of disease or could play a role in a diet aiming at preventing the development of diabetes. Public Library of Science 2020-06-24 /pmc/articles/PMC7313729/ /pubmed/32579549 http://dx.doi.org/10.1371/journal.pone.0234237 Text en © 2020 Östman et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Östman, Elin
Samigullin, Azat
Heyman-Lindén, Lovisa
Andersson, Kristina
Björck, Inger
Öste, Rickard
Humpert, Per M.
A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study
title A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study
title_full A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study
title_fullStr A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study
title_full_unstemmed A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study
title_short A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study
title_sort novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313729/
https://www.ncbi.nlm.nih.gov/pubmed/32579549
http://dx.doi.org/10.1371/journal.pone.0234237
work_keys_str_mv AT ostmanelin anovelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT samigullinazat anovelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT heymanlindenlovisa anovelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT anderssonkristina anovelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT bjorckinger anovelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT osterickard anovelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT humpertperm anovelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT ostmanelin novelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT samigullinazat novelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT heymanlindenlovisa novelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT anderssonkristina novelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT bjorckinger novelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT osterickard novelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy
AT humpertperm novelnutritionalsupplementcontainingaminoacidsandchromiumdecreasespostprandialglucoseresponseinarandomizeddoubleblindplacebocontrolledstudy